Clorox (NYSE:CLX) Stock Price Expected to Rise, Barclays Analyst Says

Clorox (NYSE:CLX) had its price target upped by equities researchers at Barclays from $130.00 to $140.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Barclays‘s price target points to a potential downside of 5.11% from the stock’s current price.

CLX has been the subject of several other reports. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and an average price target of $158.21.

Clorox Trading Up 1.1 %

Shares of NYSE:CLX opened at $147.55 on Wednesday. The stock has a 50 day moving average of $161.83 and a 200 day moving average of $158.67. The company has a market cap of $18.26 billion, a PE ratio of 51.41, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. As a group, equities research analysts expect that Clorox will post 6.86 EPS for the current year.

Institutional Trading of Clorox

Hedge funds and other institutional investors have recently bought and sold shares of the stock. State Street Corp increased its stake in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares during the period. Mizuho Securities USA LLC increased its stake in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Geode Capital Management LLC increased its stake in Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp increased its stake in Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares during the period. Finally, Van ECK Associates Corp increased its stake in Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.